Science Explorer Back to mapMap
Discussion
Researcher · Dr. Reddy's Laboratories (United States) · United States

Elimor Brand‐Schieber

Elimor Brand‐Schieber publishes mostly in Psychiatry and Mental health, Neurology and Pharmacology, on topics such as Migraine and Headache Studies, Neuroscience and Neuropharmacology Research and Vestibular and auditory disorders.

ORCID 0009-0001-8199-0020 OpenAlex
World rank
#2,510,870
of 7,710,434 ranked researchers
Rank in United States
#739,986
of 1,627,098
Works
37
Citations
1.2k
Citations per work
33.2
h-index
16
i10-index 22Top 37% in Psychiatry and Mental health
Elimor Brand‐Schieber

What does Elimor Brand‐Schieber research?

Elimor Brand‐Schieber's work is mostly in Medicine (40%), Neuroscience (21%), Biochemistry, Genetics and Molecular Biology (5%).

Health Sciences: 15 works · 40.1% of their workMedicine: 15 works · 40.1% of their workPsychiatry and Mental health: 10 works · 26.7% of their workPharmacology: 3 works · 8.6% of their workEpidemiology: 2 works · 4.8% of their workEverything else: 13 works · 34.2% of their workLife Sciences: 10 works · 25.7% of their workNeuroscience: 8 works · 20.9% of their workNeurology: 5 works · 13.3% of their workCellular and Molecular Neuroscience: 3 works · 7.6% of their workBiochemistry, Genetics and Molecular Biology: 2 works · 4.8% of their workMolecular Biology: 2 works · 4.8% of their workTHEIR WORKElimorBrand‐Schieber37works
Life Sciences26%Health Sciences40%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1540.1%
  2. Everything else1334.2%
    1. Neuroscience820.9%
    2. Biochemistry, Genetics and Molecular Biology24.8%
  1. 1Psychiatry and Mental health27% of their works
  2. 2Neurology13% of their works
  3. 3Pharmacology9% of their works
  4. 4Cellular and Molecular Neuroscience8% of their works
  5. 5Epidemiology5% of their works
  6. 6Molecular Biology5% of their works

Research topics

Which keywords describe Elimor Brand‐Schieber's research?

The keywords of their largest research topics: Neurological Disorders, Headache Disorders, Migraine, Ischemic Stroke, Neurotransmission, Synaptic Plasticity, Cerebellum and Cerebrolysin.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Neurological Disorders313 topics
  2. Headache Disorders201 topic
  3. Migraine201 topic
  4. Ischemic Stroke92 topics
  5. Neurotransmission61 topic
  6. Synaptic Plasticity61 topic
  7. Cerebellum51 topic
  8. Cerebrolysin51 topic
  9. Citicoline51 topic
  10. Neuroimaging51 topic
  11. Arachidonic Acid41 topic
  12. COVID-1941 topic
  13. Concussion41 topic
  14. Encephalopathy41 topic
  15. Epoxyeicosatrienoic Acids41 topic
  16. Microglia41 topic
  17. Neuroinflammation41 topic
  18. Olfactory Dysfunction41 topic

Where does Elimor Brand‐Schieber work?

Elimor Brand‐Schieber's main affiliation in the publication record is Dr. Reddy's Laboratories (United States), United States.

How many publications and citations does Elimor Brand‐Schieber have?

OpenAlex counts 37 works and 1,229 citations for Elimor Brand‐Schieber, an h-index of 16, ranking #2,510,870 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Elimor Brand‐Schieber. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.